# RADICALS (NCT00541047)

> RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery

No report yet. It can be ordered.

- Drugs tested: bicalutamide; goserelin; leuprolide
- Indication: prostate cancer after radical prostatectomy

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00541047
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: University College, London
- Conditions: Gastrointestinal Complications; Prostate Cancer; Sexual Dysfunction; Urinary Complications
- Interventions: bicalutamide; goserelin acetate; leuprolide acetate; adjuvant therapy; quality-of-life assessment; radiation therapy
- Enrollment: 4236
- Primary outcome: Disease-specific survival (i.e., death due to prostate cancer) (RADICALS-HD)
- Primary outcome: Freedom from distant metastases (any distance metastases or prostate cancer death) (RADICALS-RT)

## Indexed commentary on RADICALS so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3
- Bluesky threads: 2

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=radicals-nct00541047